ICBio-Initiative

ICBio-Initiative

Bengaluru, India· Est.

An Indian full-service CRO providing cost-effective, end-to-end clinical research solutions, including BA/BE studies and bioanalytical services, for global pharma and biotech clients.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

AI Company Overview

An Indian full-service CRO providing cost-effective, end-to-end clinical research solutions, including BA/BE studies and bioanalytical services, for global pharma and biotech clients.

Broad Service Provider - No Specific Therapeutic Focus

Technology Platform

Integrated clinical and bioanalytical service platform featuring state-of-the-art LC-MS/MS and ICP-MS instrumentation, a 100+ bed clinical unit, and a NABL-accredited central laboratory for end-to-end clinical research support.

Opportunities

Growth opportunities include expanding its service footprint in biosimilar and complex generic drug development, capitalizing on its regulatory approvals in emerging markets, and leveraging its extensive volunteer and patient database for faster trial recruitment.

Risk Factors

Key risks include high competition in the Indian CRO sector, regulatory and compliance risks across multiple jurisdictions, potential pricing pressure from clients, and dependence on the cyclical nature of global pharmaceutical R&D spending.

Competitive Landscape

Competes with other Indian CROs (e.g., Syngene, Lambda Therapeutic) and global CROs on cost and quality; differentiates through a strong track record in BA/BE studies, multiple international regulatory approvals, and an integrated, in-house clinical and bioanalytical infrastructure.